Skip to main content
Skip to footer
Gaylord Specialty Healthcare First in Nation to Adopt Ground-Breaking Pharyngeal Electrical Stimulation Technology to Treat Patients with Dysphagia
Read MorePhagenesis Launches Phagenyx Neurostimulation System in the U.S.
Read MorePhagenesis Selected for MedTech Innovator’s 2022 Cohort
Read MoreRapid Swallow Improvement Following Pharyngeal Electrical Stimulation In a COVID-19 Patient With Long-Term Severe Neurogenic Dysphagia: A Case Report
Read MorePharyngeal electrical stimulation helps critically ill COVID-19 patients with dysphagia recover safely: a case report using the Phagenyx® PES System
Read MoreLargest real-world study of Phagenyx® demonstrates significant benefits of treatment in patients with unsafe swallowing (neurogenic dysphagia) resulting from multiple causes
Read More